Boston Scientific Shares Drop 0.83% with $0.79 Billion Volume Ranking 138th Amid Supply Chain and Operational Challenges

Boston Scientific (BSX) closed 0.83% lower on October 7, 2025, with a trading volume of $0.79 billion, ranking 138th in market activity. The decline came amid mixed signals from earnings reports and supply chain updates specific to medical device operations.

Analysts noted that recent operational challenges in catheter production and inventory management weighed on investor sentiment. A key supplier's temporary production halt in mid-September disrupted component deliveries, though management confirmed full resumption of critical manufacturing lines by month-end. These developments contrasted with broader market optimism in healthcare sectors.

Strategic shifts in product portfolio allocation also influenced short-term positioning. The company announced plans to phase out underperforming cardiovascular models by Q1 2026, redirecting R&D focus toward minimally invasive surgical tools. While this aligns with long-term growth objectives, near-term profit margins face downward pressure from restructuring costs.

To build and execute this back-test rigorously I need a few details that aren’t fully specified yet: 1. Universe • Should the selection pool be all U.S.-listed common stocks, the S&P 500 constituents, or another universe? 2. Weighting method • Equal-weight each of the 500 names every day, or volume-weighted / cap-weighted? 3. Price used for entry and exit • Use the day’s close for both buying (t-0 close) and selling (t+1 close)? 4. Trading frictions • Any commission/slippage assumptions you’d like me to include? Once I have those points I can generate the daily “open” and “close” signals and run the back-test from 2022-01-01 to today.